BEYOND AIR INC (XAIR) Stock Fundamental Analysis

NASDAQ:XAIR • US08862L2025

1.04 USD
+0.02 (+1.96%)
Last: Feb 13, 2026, 12:50 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

XAIR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. XAIR has a bad profitability rating. Also its financial health evaluation is rather negative. XAIR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • XAIR had negative earnings in the past year.
  • XAIR had a negative operating cash flow in the past year.
  • XAIR had negative earnings in each of the past 5 years.
  • XAIR had a negative operating cash flow in each of the past 5 years.
XAIR Yearly Net Income VS EBIT VS OCF VS FCFXAIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • XAIR has a worse Return On Assets (-118.51%) than 81.72% of its industry peers.
  • XAIR has a worse Return On Equity (-288.20%) than 76.34% of its industry peers.
Industry RankSector Rank
ROA -118.51%
ROE -288.2%
ROIC N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
XAIR Yearly ROA, ROE, ROICXAIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for XAIR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XAIR Yearly Profit, Operating, Gross MarginsXAIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XAIR has been increased compared to 1 year ago.
  • The number of shares outstanding for XAIR has been increased compared to 5 years ago.
  • The debt/assets ratio for XAIR is higher compared to a year ago.
XAIR Yearly Shares OutstandingXAIR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
XAIR Yearly Total Debt VS Total AssetsXAIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -16.21, we must say that XAIR is in the distress zone and has some risk of bankruptcy.
  • XAIR's Altman-Z score of -16.21 is on the low side compared to the rest of the industry. XAIR is outperformed by 83.33% of its industry peers.
  • XAIR has a Debt/Equity ratio of 0.79. This is a neutral value indicating XAIR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.79, XAIR is doing worse than 71.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z -16.21
ROIC/WACCN/A
WACC10.73%
XAIR Yearly LT Debt VS Equity VS FCFXAIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • XAIR has a Current Ratio of 4.24. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
  • XAIR's Current ratio of 4.24 is fine compared to the rest of the industry. XAIR outperforms 70.97% of its industry peers.
  • A Quick Ratio of 3.73 indicates that XAIR has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.73, XAIR is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.24
Quick Ratio 3.73
XAIR Yearly Current Assets VS Current LiabilitesXAIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • XAIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.12%, which is quite impressive.
  • Looking at the last year, XAIR shows a very strong growth in Revenue. The Revenue has grown by 147.74%.
  • The Revenue has been growing by 21.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)73.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.68%
Revenue 1Y (TTM)147.74%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%127.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.44% on average over the next years. This is quite good.
  • XAIR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 80.94% yearly.
EPS Next Y76.18%
EPS Next 2Y36.47%
EPS Next 3Y25.56%
EPS Next 5Y15.44%
Revenue Next Year111.37%
Revenue Next 2Y143.18%
Revenue Next 3Y134%
Revenue Next 5Y80.94%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XAIR Yearly Revenue VS EstimatesXAIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
XAIR Yearly EPS VS EstimatesXAIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XAIR. In the last year negative earnings were reported.
  • Also next year XAIR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XAIR Price Earnings VS Forward Price EarningsXAIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XAIR Per share dataXAIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • XAIR's earnings are expected to grow with 25.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.47%
EPS Next 3Y25.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for XAIR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BEYOND AIR INC

NASDAQ:XAIR (2/13/2026, 12:50:29 PM)

1.04

+0.02 (+1.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10
Earnings (Next)02-13
Inst Owners20.02%
Inst Owner Change-4.69%
Ins Owners5.77%
Ins Owner Change0%
Market Cap8.33M
Revenue(TTM)5.80M
Net Income(TTM)-36.70M
Analysts80
Price Target9.18 (782.69%)
Short Float %32.26%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25.24%
Min EPS beat(2)-43.33%
Max EPS beat(2)-7.14%
EPS beat(4)2
Avg EPS beat(4)-3.68%
Min EPS beat(4)-43.33%
Max EPS beat(4)27.68%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)7
Avg EPS beat(12)-0.4%
EPS beat(16)8
Avg EPS beat(16)-10.42%
Revenue beat(2)0
Avg Revenue beat(2)-14.84%
Min Revenue beat(2)-28.34%
Max Revenue beat(2)-1.35%
Revenue beat(4)1
Avg Revenue beat(4)-8.9%
Min Revenue beat(4)-28.34%
Max Revenue beat(4)12.72%
Revenue beat(8)1
Avg Revenue beat(8)-16.12%
Revenue beat(12)1
Avg Revenue beat(12)-38.6%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)-40.14%
EPS NQ rev (3m)-11.99%
EPS NY rev (1m)-9.71%
EPS NY rev (3m)-4.24%
Revenue NQ rev (1m)1.44%
Revenue NQ rev (3m)-40.93%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-36.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.72
EV/EBITDA N/A
EPS(TTM)-7.58
EYN/A
EPS(NY)-2.17
Fwd EYN/A
FCF(TTM)-3.26
FCFYN/A
OCF(TTM)-2.95
OCFYN/A
SpS0.72
BVpS1.59
TBVpS1.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -118.51%
ROE -288.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.07%
Cap/Sales 42.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.24
Quick Ratio 3.73
Altman-Z -16.21
F-Score3
WACC10.73%
ROIC/WACCN/A
Cap/Depr(3y)311.89%
Cap/Depr(5y)350.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.68%
EPS Next Y76.18%
EPS Next 2Y36.47%
EPS Next 3Y25.56%
EPS Next 5Y15.44%
Revenue 1Y (TTM)147.74%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%127.82%
Revenue Next Year111.37%
Revenue Next 2Y143.18%
Revenue Next 3Y134%
Revenue Next 5Y80.94%
EBIT growth 1Y40.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.12%
OCF growth 3YN/A
OCF growth 5YN/A

BEYOND AIR INC / XAIR FAQ

What is the fundamental rating for XAIR stock?

ChartMill assigns a fundamental rating of 3 / 10 to XAIR.


Can you provide the valuation status for BEYOND AIR INC?

ChartMill assigns a valuation rating of 1 / 10 to BEYOND AIR INC (XAIR). This can be considered as Overvalued.


How profitable is BEYOND AIR INC (XAIR) stock?

BEYOND AIR INC (XAIR) has a profitability rating of 0 / 10.


What is the financial health of BEYOND AIR INC (XAIR) stock?

The financial health rating of BEYOND AIR INC (XAIR) is 3 / 10.